A cell-impermeable luminogenic probe for near-infrared imaging of prostate-specific membrane antigen in prostate cancer microenvironments

Xifang Yang,Sang-Cuo Nao,Chuankai Lin,Lingtan Kong,Jing Wang,Chung-Nga Ko,Jinbiao Liu,Dik-Lung Ma,Chung-Hang Leung,Wanhe Wang
DOI: https://doi.org/10.1016/j.ejmech.2023.115659
IF: 7.088
2023-07-27
European Journal of Medicinal Chemistry
Abstract:Prostate-specific membrane antigen (PSMA) imaging probes are a promising tool for the diagnosis and image-guided surgery of prostate cancer (PCa). However, PSMA-specific luminescence probes for PCa detection and heterogeneity studies with high imaging contrast are lacking. Here, we report the first near-infrared (NIR) iridium(III) complex for the wash-free and specific imaging of PSMA in PCa cells and spheroids. The conjugation of a PSMA inhibitor, Lys-urea-Glu, to an iridium(III) complex synergizes the PSMA-specific affinity and biocompatibility of the inhibitor with the desirable photophysical properties of the iridium(III) complex, including NIR emission (670 nm), high photostability and a large Stokes shift. The cellular impermeability of the probe along with its strong binding affinity to PSMA enhances its specificity for PSMA, enabling the washing-free luminescent imaging of membrane PSMA with lower cytotoxicity. The probe was successfully applied for selectively visualizing PSMA-expressing cells and for the imaging of PSMA in a multicellular PCa model with good imaging penetration, indicating its potential use in complicated and heterogeneous tumor microenvironments. Furthermore, the probe showed good imaging performance in the PCa-bearing tumor mice via targeting PSMA in vivo . This work provides a novel strategy for the development of highly sensitive and specific NIR probes for PSMA in biological systems in vitro , which is of great significance for the precise diagnosis of PCa and for elucidating PCa heterogeneity.
chemistry, medicinal
What problem does this paper attempt to address?